Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

Blood (2018) 132 (Supplement 1): 253.

https://doi.org/10.1182/blood-2018-99-111203

Published: 2018

Journal Articles

Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

Blood (2018) 132 (Supplement 1): 254.

https://doi.org/10.1182/blood-2018-99-119762

Published: 2018

Journal Articles

Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

Blood (2018) 132 (Supplement 1): 4485.

https://doi.org/10.1182/blood-2018-99-113284

Published: 2018

Journal Articles

AL Amyloidosis — Pathogenesis and Prognosis Are Determined By the Amyloidogenic Potential of the Light Chain and the Molecular Characteristics of Malignant Plasma Cells

Anja Seckinger, Ute Hegenbart, Susanne Beck, Martina Emde, Tilmann Bochtler, Christoph Kimmich, Carsten Müller-Tidow, MD, Anna Jauch, PhD, Stefan Schönland, Dirk Hose, MD

Blood (2018) 132 (Supplement 1): 187.

https://doi.org/10.1182/blood-2018-187

Published: 2018

Journal Articles

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Tilmann Bochtler, MD, Martin Granzow, PhD, Friedrich Stölzel, MD, Christina Kunz, PhD, Brigitte Mohr, PhD, Mutlu Kartal-Kaess, MD, Johannes W.G. Janssen, PhD, Christoph E. Heilig, MD, Michael Kramer, MSc, Christian Thiede, MD, Axel Benner, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Anna Jauch, PhD, Alwin Krämer, MD

Blood (2016) 128 (22): 2869.

https://doi.org/10.1182/blood.V128.22.2869.2869

Published: 2016

Journal Articles

Longitudinal Fluorescence in Situ Hybridization at Primary Diagnosis and Relapse Reveals Clonal Evolution after Autologous Stem Cell Transplantation in Multiple Myeloma

Maximilian Merz, MD, Thomas Hielscher, Anja Seckinger, MD, Dirk Hose, MD, Uta Bertsch, MD, Kai Neben, MD, Marc S Raab, MD, Igor Blau, Hans Walter Lindemann, MD, Ingo GH Schmidt-Wolf, MD, Christof Scheid, MD PhD, Mathias Haenel, MD, Katja Weisel, MD, Hartmut Goldschmidt, MD, Anna Jauch, PhD, Jens Hillengass, MD

Blood (2016) 128 (22): 4415.

https://doi.org/10.1182/blood.V128.22.4415.4415

Published: 2016

Journal Articles

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Blood (2016) 128 (22): 235.

https://doi.org/10.1182/blood.V128.22.235.235

Published: 2016

Journal Articles

Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry

Stefan Schönland, MD, Ute Hegenbart, MD, Christoph Kimmich, Katarina Lisenko, MD, Dirk Hose, MD PhD, Hartmut Goldschmidt, MD, Anna Jauch, PhD, Anthony D. Ho, Prof., MD FRCPC, Michael Hundemer, MD

Blood (2014) 124 (21): 2068.

https://doi.org/10.1182/blood.V124.21.2068.2068

Published: 2014

Journal Articles

Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG

Christof Scheid, MDPhD, Thomas Hielscher, Uta Bertsch, MD, Christina Kunz, PhD, Hans Salwender, MD, Mathias Haenel, Maximilian Merz, Elias Karl Mai, MD, Dirk Hose, MD PhD, Baerbel Schurich, PhD, Markus Munder, MD, Ingo Schmidt-Wolf, MD, Christian Gerecke, MD, Walter Lindemann, MD, Matthias Zeis, MD, Katja Weisel, MD, Jan Duerig, MD, Anna Jauch, PhD, Hartmut Goldschmidt, MD

Blood (2014) 124 (21): 4777.

https://doi.org/10.1182/blood.V124.21.4777.4777

Published: 2014

Journal Articles

Expression Of Aldehyde Dehydrogenase Reflected Diverse Stem Cell Properties In Acute Myeloid Leukemia

Van T. Hoang, Eike C. Buss, MD, Isabel Hoffmann, PhD, Abraham Zepeda-Moreno, MD, Natalia Baran, Volker Eckstein, PhD, Anna Jauch, PhD, Anthony D. Ho, MD

Blood (2013) 122 (21): 1344.

https://doi.org/10.1182/blood.V122.21.1344.1344

Published: 2013

Journal Articles

GMMG MM5 Trial In Newly Diagnosed Multiple Myeloma To Evaluate PAd Vs VCD Induction Prior To High Dose Treatment Followed By Lenalidomide Consolidation and Maintenance – Final Analysis On Induction Therapy

Blood (2013) 122 (21): 3369.

https://doi.org/10.1182/blood.V122.21.3369.3369

Published: 2013

Journal Articles

Systematic Mapping Of Drug and Pathway Sensitivity In Chronic Lymphocytic Leukemia Identifies Synthetic Lethal Interactions Of Mutant p53

Leopold Sellner, MD, Oles Malgorzata, Mikolaj Slabicki, PhD, Carolin Blume, Hüllein Jennifer, Tatjana Stolz, Martin Sill, PhD, Sascha Dietrich, MD, Olaf Merkel, PhD, Anna Jauch, PhD, Manfred Hensel, MD, Davide Rossi, Zirlik Katja, MD, Martina Seiffert, PhD, Anthony D. Ho, MD, von Kalle Christof, MD, Hanno Glimm, MD, Wolfgang Huber, PhD, Thorsten Zenz, MD

Blood (2013) 122 (21): 173.

https://doi.org/10.1182/blood.V122.21.173.173

Published: 2013

Journal Articles

Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial

Blood (2013) 122 (21): 404.

https://doi.org/10.1182/blood.V122.21.404.404

Published: 2013

Journal Articles

The Chromosomal Abnormalities Del(17p), t(4;14), and +1q21 Predict Progression From Smoldering to Symptomatic Multiple Myeloma

Kai Neben, MD, Anna Jauch, PhD, Thomas Hielscher, Jens Hillengass, MD, Nicola Lehners, MD, Marc S Raab, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD

Blood (2012) 120 (21): 1806.

https://doi.org/10.1182/blood.V120.21.1806.1806

Published: 2012

Journal Articles

Gain of 1q21 Is a Cytogenetic Independent Risk Factor in Light Chain Amyloidosis Patients Treated with Melphalan / Dexamethasone As First-Line Therapy,

Tilmann Bochtler, MD, Ute Hegenbart, MD, Axel Benner, Dirk Hose, MD, Anja Seckinger, Kai Neben, MD, Sascha Dietrich, MD, Claus R Bartram, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Anna Jauch, PhD, Stefan O Schonland, MD

Blood (2011) 118 (21): 3946.

https://doi.org/10.1182/blood.V118.21.3946.3946

Published: 2011

Journal Articles

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Blood (2011) 118 (21): 332.

https://doi.org/10.1182/blood.V118.21.332.332

Published: 2011

Journal Articles

Mesenchymal Stromal Cells Derived from Human Non-Small Cell Lung Cancer, Normal Lung Tissue, and Bone Marrow: Differences in Frequency, Cytogenetics, Proliferation Behavior, and Chemosensitivity - Implications for Cancer Therapy.

Sandra Gottschling, MD, Michael Meister, PhD, Anna Jauch, PhD, Ulf C. Krause, MD, Anja Seckinger, MD, Hans Hoffmann, MD, Hendrik Dienemann, MD, Ho D. Anthony, MD PhD, Michael Thomas, MD

Blood (2007) 110 (11): 1925.

https://doi.org/10.1182/blood.V110.11.1925.1925

Published: 2007

Journal Articles

Ribosomal Proteins Are Overexpressed in Hyperdiploid Multiple Myeloma.

Niels Weinhold, John DeVos, PhD, Dirk Hose, Jean-Francois Rossi, MD, Benner Axel, Karène Mahtouk, PhD, Marc S. Raab, MD, Thierry X. Rème, PhD, Anna Jauch, PhD, Jerome Moreaux, PhD, Veronique Pantesco, Hartmut Goldschmidt, MD, Eric Jourdan, MD, Friedrich W. Cremer, MD, Bernard Klein, MD, PhD, Marion Moos, PhD

Blood (2007) 110 (11): 2495.

https://doi.org/10.1182/blood.V110.11.2495.2495

Published: 2007

Journal Articles

Evaluation of the Cytogenetic Aberration Pattern in AL Amyloidosis Compared to Monoclonal Gammopathies Not Requiring Treatment: Translocation t(11;14) Is More Frequent in AL Amyloidosis.

Tilmann Bochtler, MD, Stefan O. Schonland, MD, Anna Jauch, PhD, Christiane Heiss, Axel Benner, PhD, Friedrich W. Cremer, MD, Dirk Hose, Marion Moos, PhD, Claus R. Bartram, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Ute Hegenbart, MD

Blood (2007) 110 (11): 2500.

https://doi.org/10.1182/blood.V110.11.2500.2500

Published: 2007

Journal Articles

Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.

Blood (2007) 110 (11): 503.

https://doi.org/10.1182/blood.V110.11.503.503

Published: 2007

NARROW

Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

AL Amyloidosis — Pathogenesis and Prognosis Are Determined By the Amyloidogenic Potential of the Light Chain and the Molecular Characteristics of Malignant Plasma Cells

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Longitudinal Fluorescence in Situ Hybridization at Primary Diagnosis and Relapse Reveals Clonal Evolution after Autologous Stem Cell Transplantation in Multiple Myeloma

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry

Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG

Expression Of Aldehyde Dehydrogenase Reflected Diverse Stem Cell Properties In Acute Myeloid Leukemia

GMMG MM5 Trial In Newly Diagnosed Multiple Myeloma To Evaluate PAd Vs VCD Induction Prior To High Dose Treatment Followed By Lenalidomide Consolidation and Maintenance – Final Analysis On Induction Therapy

Systematic Mapping Of Drug and Pathway Sensitivity In Chronic Lymphocytic Leukemia Identifies Synthetic Lethal Interactions Of Mutant p53

Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial

The Chromosomal Abnormalities Del(17p), t(4;14), and +1q21 Predict Progression From Smoldering to Symptomatic Multiple Myeloma

Gain of 1q21 Is a Cytogenetic Independent Risk Factor in Light Chain Amyloidosis Patients Treated with Melphalan / Dexamethasone As First-Line Therapy,

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Mesenchymal Stromal Cells Derived from Human Non-Small Cell Lung Cancer, Normal Lung Tissue, and Bone Marrow: Differences in Frequency, Cytogenetics, Proliferation Behavior, and Chemosensitivity - Implications for Cancer Therapy.

Ribosomal Proteins Are Overexpressed in Hyperdiploid Multiple Myeloma.

Evaluation of the Cytogenetic Aberration Pattern in AL Amyloidosis Compared to Monoclonal Gammopathies Not Requiring Treatment: Translocation t(11;14) Is More Frequent in AL Amyloidosis.

Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only